Search research articles
Contact Us
Filters
Showing results (121-130 of 136) with videos related to
Page
of 14
Sort By:
Pathology, Research and Practice
|
January 21, 2024
Tuning into miRNAs: A comprehensive analysis of their impact on diagnosis, and progression in asthma
Mahmoud A Elrebehy, Ahmed I Abulsoud, Walaa A El-Dakroury, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
October 1, 2025
Activation of nicotinamide phosphoribosyltransferase protects against unilateral renal ischemia-reperfusion injury via the NAD<sup>+</sup>/SIRT1/PGC-1α signaling pathway and modulation of NFκB/TNF-α/IL-6
Elsayed A Elmorsy, Mostafa M Khodeir, Manal M Kamal, et al.
Life Sciences
|
August 15, 2024
Modulating the HSP90 control over NFκB/NLRP3/Caspase-1 axis is a new therapeutic target in the management of liver fibrosis: Insights into the role of TAS-116 (Pimitespib)
Elsayed A Elmorsy, Sameh Saber, Rabab S Hamad, et al.
Life Sciences
|
June 7, 2024
Hedgehog signaling mastery: R51211's promise in augmenting the therapeutic efficacy of sorafenib
Alexandru Madalin Hasan, Simona Cavalu, Sameh Saber, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 14, 2024
Linagliptin, a DPP-4 inhibitor, activates AMPK/FOXO3a and suppresses NFκB to mitigate the debilitating effects of diethylnitrosamine exposure in rat liver: Novel mechanistic insights
Rasha Abdelhady, Osama A Mohammed, Ahmed S Doghish, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
May 7, 2024
A novel combination therapy targets sonic hedgehog signaling by the dual inhibition of HMG-CoA reductase and HSP90 in rats with non-alcoholic steatohepatitis
Osama A Mohammed, Mahmoud E Youssef, Ahmed S Doghish, et al.
Tissue & Cell
|
June 26, 2026
Interrupting a mitochondrial DNA-driven innate immune circuit attenuates hepatic tissue remodeling and fibrotic architecture in experimental steatohepatitis
Rabab S Hamad, Sura Akram Mohammed, Waseem Ali Hasan, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
April 11, 2025
E1231/SR647 protects against unilateral renal ischemia-reperfusion injury by modulating SIRT1/FOXO3 interactions with Nrf2 and NFκB pathways
Sameh Saber, Rabab S Hamad, Elsayed A Elmorsy, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 14, 2023
Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling
Sameh Saber, Eslam E Abd El-Fattah, Amir Mohamed Abdelhamid, et al.
Pathology, Research and Practice
|
December 11, 2023
Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Parkinson's disease
Osama A Mohammed, Mohammed S Elballal, Ahmed A El-Husseiny, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 136) with videos related to
Sort By:
Page
of 14
Pathology, Research and Practice
|
January 21, 2024
Tuning into miRNAs: A comprehensive analysis of their impact on diagnosis, and progression in asthma
Mahmoud A Elrebehy, Ahmed I Abulsoud, Walaa A El-Dakroury, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
October 1, 2025
Activation of nicotinamide phosphoribosyltransferase protects against unilateral renal ischemia-reperfusion injury via the NAD<sup>+</sup>/SIRT1/PGC-1α signaling pathway and modulation of NFκB/TNF-α/IL-6
Elsayed A Elmorsy, Mostafa M Khodeir, Manal M Kamal, et al.
Life Sciences
|
August 15, 2024
Modulating the HSP90 control over NFκB/NLRP3/Caspase-1 axis is a new therapeutic target in the management of liver fibrosis: Insights into the role of TAS-116 (Pimitespib)
Elsayed A Elmorsy, Sameh Saber, Rabab S Hamad, et al.
Life Sciences
|
June 7, 2024
Hedgehog signaling mastery: R51211's promise in augmenting the therapeutic efficacy of sorafenib
Alexandru Madalin Hasan, Simona Cavalu, Sameh Saber, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 14, 2024
Linagliptin, a DPP-4 inhibitor, activates AMPK/FOXO3a and suppresses NFκB to mitigate the debilitating effects of diethylnitrosamine exposure in rat liver: Novel mechanistic insights
Rasha Abdelhady, Osama A Mohammed, Ahmed S Doghish, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
May 7, 2024
A novel combination therapy targets sonic hedgehog signaling by the dual inhibition of HMG-CoA reductase and HSP90 in rats with non-alcoholic steatohepatitis
Osama A Mohammed, Mahmoud E Youssef, Ahmed S Doghish, et al.
Tissue & Cell
|
June 26, 2026
Interrupting a mitochondrial DNA-driven innate immune circuit attenuates hepatic tissue remodeling and fibrotic architecture in experimental steatohepatitis
Rabab S Hamad, Sura Akram Mohammed, Waseem Ali Hasan, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
April 11, 2025
E1231/SR647 protects against unilateral renal ischemia-reperfusion injury by modulating SIRT1/FOXO3 interactions with Nrf2 and NFκB pathways
Sameh Saber, Rabab S Hamad, Elsayed A Elmorsy, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 14, 2023
Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling
Sameh Saber, Eslam E Abd El-Fattah, Amir Mohamed Abdelhamid, et al.
Pathology, Research and Practice
|
December 11, 2023
Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Parkinson's disease
Osama A Mohammed, Mohammed S Elballal, Ahmed A El-Husseiny, et al.
Page
of 14